Martin Auster, Chief Financial Officer at Ventyx Biosciences, Inc. (VTYX), sold 42,000 shares at $30.24 ($1.3M) on 2023-04-04, disclosed to the SEC on 2023-04-05.
Open-market sale of $1.3M VTYX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.24 | 9,577 | $290K | 22.4% |
| 2 | $30.24 | 9,577 | $290K | 22.4% |
| 3 | $31.07 | 9,535 | $296K | 22.9% |
| 4 | $31.07 | 9,535 | $296K | 22.9% |
| 5 | $31.86 | 1,888 | $60K | 4.7% |
| 6 | $31.86 | 1,888 |
| $60K |
| 4.7% |
| Total | $30.76 avg | 42,000 | $1.3M | 100% |
| Filing → |
| VTYX | SELL | 2023-07-26 | $995K | — | Filing → |
| VTYX | SELL | 2023-06-07 | $1.9M | — | Filing → |
| VTYX | SELL | 2023-04-27 | $2.1M | — | Filing → |